Get started
Author

Yurdagul Danacı

Observed names: Danacı, Yurdagül, Yurdagül Danacı, Yurdagül Sağır Danacı
Institution: Inonu University
Observed institution: Inonu University
ORCID: 0009-0000-2414-8665
Observed ORCID: 0009-0000-2414-8665
OpenAlex ID: A5120161582
Real‐world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple‐negative breast cancer: A multicenter study by the Turkish Oncology Group
2025 · Salih Tunbekici, Gokhan Sahin, et al. · International Journal of Cancer · 3
Diabetes Increases Immunotherapy‐Related Toxicity but Not Efficacy in Metastatic Non‐Small Cell Lung Cancer: A Multicenter Retrospective Study
2026 · Emre Çakır, Didem Divriklioğlu, et al. · International Journal of Cancer
PDF
Pretreatment Prognostic Nutritional Index Predicts Progression-Free Survival in BCLC Stage C Hepatocellular Carcinoma Treated with Sorafenib
2026 · Umut Aydın, Mustafa Dikilitaş, et al. · Cancer Management and Research
The efficacy of targeted therapies in metastatic squamous cell carcinoma of the lung: a Turkish Oncology Group multicentre study
2025 · Bilgeşah Kılıçtaş, Murat Araz, et al. · Journal of Chemotherapy
Metastatik Mesane Kanserinde Sistemik Tedaviler
2025 · Yurdagül Danacı · Akademisyen Kitabevi eBooks
PDF
Ürogenital Sistem Kanserleri
2025 · Leyla Beytur, Fırat Çağlar Budak, et al. · Akademisyen Kitabevi eBooks
PDF
The efficacy of targeted therapies in metastatic squamous cell carcinoma of the lung: a Turkish Oncology Group multicentre study
2025 · Kılıçtaş, Bilgeşah, Araz, Murat, et al. · Figshare
The Effect of Tnf-alpha Inhibitors Used in Rheumatologic Diseases on Hematological Parameters
2024 · Rabia Pişkin Sağır, Servet Yolbaş, et al. · Rheumatology Quarterly
PDF
Works count: 8
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type